Boiling and ready to burst as Oragenics Inc. (OGEN) last month performance was -13.63%

For the readers interested in the stock health of Oragenics Inc. (OGEN). It is currently valued at $0.55. When the transactions were called off in the previous session, Stock hit the highs of $0.57, after setting-off with the price of $0.53. Company’s stock value dipped to $0.52 during the trading on the day. When the trading was stopped its value was $0.54.

Recently in News on October 6, 2020, FDA Broadly Supports Oragenics’ Pre-IND Development Program for its SARS-CoV-2 Vaccine. Re-Affirms Plan to File IND Application by the End of 1Q21, Begin Phase 1 Study in Early 2Q21. You can read further details here

My Next COVID-19 Stock Alert Poised For Triple Digit Moves

Get Ready for my next COVID-19 stock idea. I have been very fortunate in discovering biotech, therapeutic and diagnostic companies within the COVID-19 space, before wall street catches on. Our goal for our members is to get our Alert’s first before the crowd.    

>> Sign Up Now to Get Name & Ticker Symbol of Next Triple-Digit Gainer <<


Oragenics Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.0900 on 07/22/20, with the lowest value was $0.3600 for the same time period, recorded on 04/16/20.

Oragenics Inc. (OGEN) full year performance was 22.37%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Oragenics Inc. shares are logging -73.80% during the 52-week period from high price, and 52.11% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.36 and $2.09.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2592613 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Oragenics Inc. (OGEN) recorded performance in the market was 4.70%, having the revenues showcasing -50.67% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 33.65M, as it employees total of 7 workers.

Oragenics Inc. (OGEN) in the eye of market guru’s

During the last month, 1 analysts gave the Oragenics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 1 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 0.7731, with a change in the price was noted -0.0076. In a similar fashion, Oragenics Inc. posted a movement of -1.37% for the period of last 100 days, recording 6,380,875 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for OGEN is recording 0.06 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

Oragenics Inc. (OGEN): Stocks Technical analysis and Trends

Raw Stochastic average of Oragenics Inc. in the period of last 50 days is set at 5.49%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 11.97%. In the last 20 days, the company’s Stochastic %K was 9.47% and its Stochastic %D was recorded 7.66%.

If we look into the earlier routines of Oragenics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 4.70%. Additionally, trading for the stock in the period of the last six months notably improved by 28.30%, alongside a boost of 22.37% for the period of the last 12 months. The shares increased approximately by -3.15% in the 7-day charts and went up by -13.63% in the period of the last 30 days. Common stock shares were lifted by -50.67% during last recorded quarter.

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free